CIBION 24492
CENTRO DE INVESTIGACIONES EN BIONANOCIENCIAS "ELIZABETH JARES ERIJMAN"
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Non-targeted Metabolomics: A strategy for discovering potential clear cell Renal Cell Carcinoma biomarkers
Autor/es:
NICOLÁS ZABALEGUI; LYDIA INÉS PURICELLI; MARÍA ELENA KNOTT; MALENA MANZI; MARÍA EUGENIA MONGE
Lugar:
Ciudad de Buenos Aires
Reunión:
Simposio; Frontiers in Bioscience 3; 2018
Institución organizadora:
Max Planck Society
Resumen:
Renal Cell Carcinoma (RCC) is among the 10 most common cancers in both men and women, being clear cell renal cell carcinoma (ccRCC) the most common (75-80%) lethal subtype of kidney cancer. More than 50% of the patients exhibit locally advanced or metastatic RCC at the time of diagnosis and have a poor prognosis (5-year survival rate
